Recent Developments in Hepatic Drug Oxidation
- 1 March 1990
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 18 (3), 220-239
- https://doi.org/10.2165/00003088-199018030-00004
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- Bioactivation of the narcotic drug codeine in human liver is mediated by the polymorphic monooxygenase catalyzing debrisoquine 4-hydroxylation (cytochrome P-450 dbl/bufI)Biochemical and Biophysical Research Communications, 1988
- The P450 Gene Superfamily: Recommended NomenclatureDNA, 1987
- The molecular mechanisms of two common polymorphisms of drug oxidation-evidence for functional changes in cytochrome P-450 isozymes catalysing bufuralol and mephenytoin oxidationXenobiotica, 1986
- Pharmacokinetics of N-propylajmaline in relation to polymorphic sparteine oxidationKlinische Wochenschrift, 1985
- Characterization of a common genetic defect of cytochrome P-450 function (debrisoquine-sparteine type polymorphism) — Increased michaelis constant (km) and loss of stereoselectivity of bufuralol 1′-hydroxylation in poor metabolizersBiochemical and Biophysical Research Communications, 1984
- Debrisoquine-type polymorphism of drug oxidation: purification from human liver of a cytochrome P450 isozyme with high activity for bufuralol hydroxylationFEBS Letters, 1984
- Competitive inhibition of sparteine oxidation in human liver by β-adrenoceptor antagonists and other cardiovascular drugsLife Sciences, 1984
- Correlation between nortriptyline and debrisoquine hydroxylation in the human liverLife Sciences, 1983
- Interindividual and interspecies variation in the metabolism of the hallucinogen 4-methoxyamphetamineXenobiotica, 1979
- Relationship between Dose and Plateau Levels of Drugs Eliminated by Parallel First-Order and Capacity-Limited KineticsJournal of Pharmaceutical Sciences, 1972